Stryker Corporation 8-K
Leadership change
Board expands to add Quest Diagnostics CEO James E. Davis, effective Jan. 1, 2027.
Filed 2026-11-09 16:16 ET
- 5.02 Officer/director change
- 7.01 Regulation FD Disclosure
- 9.01 Financial Statements and Exhibits
Summary
Stryker board appointment: the board expanded from 11 to 12 directors and elected James E. Davis to the new seat, effective 1/1/2027. Davis is chairman, CEO and president of Quest Diagnostics and has prior medical-device and healthcare leadership experience, including as CEO of InSightec and leadership of GE’s MRI business. He will receive compensation consistent with Stryker’s other non-employee directors and has not been assigned to a board committee.
The summary is written by an AI model reading the filing.
Model 005 · prompt v192 · 2026-11-09 23:39:46Z